Characterisation of novel therapies to mitigate inflammation in retinal degenerations
Inflammation is established as a key factor in mediating the
progression of a number of retinal degenerations, including both
wet and dry age-related macular degeneration (AMD) [1-3].
MicroRNAs (miRNAs) are a class of endogenously occurring
non-coding RNA (ncRNA) molecules that are gaining momentum as
therapeutic targets for treating a number of human conditions
[4-6] and have been identified to modulate inflammation . The
purpose of this study is to...[Show more]
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.